Development of hepatocellular carcinoma in patients with chronic hepatitis C who had sustained viral response following direct-acting antiviral therapy

BACKGROUND AND AIM: Several studies have suggested that treatment with direct-acting antivirals (DAAs) in patients with chronic hepatitis C virus (HCV) may be associated with an increased risk of developing hepatocellular carcinoma (HCC). We investigated the incidence and risk factors of HCC in HCV...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebik, Berat, Aygan, Mustafa, Tuncel, Elif Tugba, Kacmaz, Huseyin, Ekin, Nazim, Arpa, Medeni, Yalcin, Kendal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510740/
https://www.ncbi.nlm.nih.gov/pubmed/36177099
http://dx.doi.org/10.14744/hf.2022.2022.0016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510740/
https://www.ncbi.nlm.nih.gov/pubmed/36177099
http://dx.doi.org/10.14744/hf.2022.2022.0016

Ejemplares similares